Rangit Vallapureddy

970 total citations
16 papers, 446 citations indexed

About

Rangit Vallapureddy is a scholar working on Genetics, Hematology and Molecular Biology. According to data from OpenAlex, Rangit Vallapureddy has authored 16 papers receiving a total of 446 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Genetics, 10 papers in Hematology and 7 papers in Molecular Biology. Recurrent topics in Rangit Vallapureddy's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (11 papers), Acute Myeloid Leukemia Research (9 papers) and Kruppel-like factors research (4 papers). Rangit Vallapureddy is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (11 papers), Acute Myeloid Leukemia Research (9 papers) and Kruppel-like factors research (4 papers). Rangit Vallapureddy collaborates with scholars based in United States, Italy and Canada. Rangit Vallapureddy's co-authors include Ayalew Tefferi, Terra L. Lasho, Rhett P. Ketterling, Naseema Gangat, Christy M. Finke, Curtis A. Hanson, Animesh Pardanani, Mrinal M. Patnaik, Domenico Penna and Natasha Szuber and has published in prestigious journals such as Blood, Journal of the American Society of Nephrology and Mayo Clinic Proceedings.

In The Last Decade

Rangit Vallapureddy

15 papers receiving 445 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rangit Vallapureddy United States 10 352 313 219 102 37 16 446
Dilan Paranagama United States 12 576 1.6× 436 1.4× 285 1.3× 266 2.6× 47 664
Meira Zoldan Israel 8 116 0.3× 154 0.5× 53 0.2× 31 0.3× 4 0.1× 9 306
Sabrina Caberlon Italy 8 264 0.8× 218 0.7× 156 0.7× 110 1.1× 2 0.1× 12 349
Jean‐Loup Demory France 8 570 1.6× 491 1.6× 269 1.2× 175 1.7× 1 0.0× 14 641
Ghaith Abu‐Zeinah United States 7 145 0.4× 98 0.3× 96 0.4× 118 1.2× 1 0.0× 44 254
Shireen Sirhan Canada 14 557 1.6× 384 1.2× 331 1.5× 250 2.5× 35 594
Chang‐Liang Lai Taiwan 7 161 0.5× 347 1.1× 169 0.8× 22 0.2× 10 408
Marta Bellini Italy 6 475 1.3× 335 1.1× 334 1.5× 180 1.8× 10 511
Federico Vozella Italy 10 81 0.2× 162 0.5× 82 0.4× 46 0.5× 31 241
Constantinos Pamboukas Greece 6 91 0.3× 141 0.5× 252 1.2× 23 0.2× 4 0.1× 10 325

Countries citing papers authored by Rangit Vallapureddy

Since Specialization
Citations

This map shows the geographic impact of Rangit Vallapureddy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rangit Vallapureddy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rangit Vallapureddy more than expected).

Fields of papers citing papers by Rangit Vallapureddy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rangit Vallapureddy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rangit Vallapureddy. The network helps show where Rangit Vallapureddy may publish in the future.

Co-authorship network of co-authors of Rangit Vallapureddy

This figure shows the co-authorship network connecting the top 25 collaborators of Rangit Vallapureddy. A scholar is included among the top collaborators of Rangit Vallapureddy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rangit Vallapureddy. Rangit Vallapureddy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Vallapureddy, Rangit, Terra L. Lasho, Christy M. Finke, et al.. (2019). Suboptimal response rates to hypomethylating agent therapy in chronic myelomonocytic leukemia; a single institutional study of 121 patients. American Journal of Hematology. 94(7). 767–779. 49 indexed citations
2.
Vallapureddy, Rangit, Mythri Mudireddy, Domenico Penna, et al.. (2019). Leukemic transformation among 1306 patients with primary myelofibrosis: risk factors and development of a predictive model. Blood Cancer Journal. 9(2). 12–12. 48 indexed citations
3.
Szuber, Natasha, Mythri Mudireddy, Maura Nicolosi, et al.. (2019). 3023 Mayo Clinic Patients With Myeloproliferative Neoplasms: Risk-Stratified Comparison of Survival and Outcomes Data Among Disease Subgroups. Mayo Clinic Proceedings. 94(4). 599–610. 107 indexed citations
4.
Penna, Domenico, Terra L. Lasho, Christy M. Finke, et al.. (2018). 20+ Years and alive with primary myelofibrosis: Phenotypic signature of very long‐lived patients. American Journal of Hematology. 94(3). 286–290. 8 indexed citations
5.
Patnaik, Mrinal M., Rangit Vallapureddy, Terra L. Lasho, et al.. (2018). A comparison of clinical and molecular characteristics of patients with systemic mastocytosis with chronic myelomonocytic leukemia to CMML alone. Leukemia. 32(8). 1850–1856. 20 indexed citations
6.
Tefferi, Ayalew, Natasha Szuber, Rangit Vallapureddy, et al.. (2018). Decreased survival and increased rate of fibrotic progression in essential thrombocythemia chronicled after the FDA approval date of anagrelide. American Journal of Hematology. 94(1). 5–9. 9 indexed citations
7.
Patnaik, Mrinal M., Ana Alfonso Piérola, Rangit Vallapureddy, et al.. (2018). Blast phase chronic myelomonocytic leukemia: Mayo-MDACC collaborative study of 171 cases. Leukemia. 32(11). 2512–2518. 16 indexed citations
8.
Shenoy, Niraj, Mythri Mudireddy, Rangit Vallapureddy, et al.. (2018). Association Between Renal Cell Carcinoma and Myelodysplastic Syndromes: Epigenetic Underpinning?. Clinical Genitourinary Cancer. 16(6). e1117–e1122. 1 indexed citations
9.
Szuber, Natasha, Mythri Mudireddy, Maura Nicolosi, et al.. (2018). 3,023 Mayo Clinic Patients with Myeloproliferative Neoplasms: Risk-Stratified Comparison of Survival and Outcomes Data Among Disease Subgroups. Blood. 132(Supplement 1). 3035–3035. 24 indexed citations
10.
Tefferi, Ayalew, Paola Guglielmelli, Terra L. Lasho, et al.. (2018). Mutation-Enhanced International Prognostic Systems for Essential Thrombocythemia (MIPSS-ET) and Polycythemia Vera (MIPSS-PV). Blood. 132(Supplement 1). 578–578. 7 indexed citations
11.
Guglielmelli, Paola, Naseema Gangat, Giacomo Coltro, et al.. (2018). Mutations and Thrombosis in Essential Thrombocythemia and Polycythemia Vera: Mayo-Careggi Alliance Study. Blood. 132(Supplement 1). 3040–3040. 1 indexed citations
12.
Szuber, Natasha, Rangit Vallapureddy, Domenico Penna, et al.. (2018). Myeloproliferative neoplasms in the young: Mayo Clinic experience with 361 patients age 40 years or younger. American Journal of Hematology. 93(12). 1474–1484. 56 indexed citations
13.
Nicolosi, Maura, Domenico Penna, Mythri Mudireddy, et al.. (2018). Cytogenetic Clonal Evolution in Myeloproliferative Neoplasms: Contexts and Prognostic Impact Among 650 Patients with Serial Bone Marrow Biopsies. Blood. 132(Supplement 1). 4291–4291. 1 indexed citations
14.
Penna, Domenico, Maura Nicolosi, Mythri Mudireddy, et al.. (2018). 20+ Years and Alive with Primary Myelofibrosis: Phenotypic Signature of Very Long-Lived Patients. Blood. 132(Supplement 1). 4301–4301.
15.
Patnaik, Mrinal M., Rangit Vallapureddy, Fevzi Yalniz, et al.. (2017). Therapy related‐chronic myelomonocytic leukemia (CMML): Molecular, cytogenetic, and clinical distinctions from de novo CMML. American Journal of Hematology. 93(1). 65–73. 41 indexed citations
16.
Anderson, Ulrik Dolberg, Muthuvel Jayachandran, Tracey L. Weissgerber, et al.. (2017). Urinary Extracellular Vesicles of Podocyte Origin and Renal Injury in Preeclampsia. Journal of the American Society of Nephrology. 28(11). 3363–3372. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dilan Paranagama Breakdown of academic impact, for papers by Meira Zoldan Breakdown of academic impact, for papers by Sabrina Caberlon Breakdown of academic impact, for papers by Jean‐Loup Demory Breakdown of academic impact, for papers by Ghaith Abu‐Zeinah Breakdown of academic impact, for papers by Shireen Sirhan Breakdown of academic impact, for papers by Chang‐Liang Lai Breakdown of academic impact, for papers by Marta Bellini Breakdown of academic impact, for papers by Federico Vozella Breakdown of academic impact, for papers by Constantinos Pamboukas
Rankless by CCL
2026